Systemic lupus erythematosus risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Systemic lupus erythematosus}} | {{Systemic lupus erythematosus}} | ||
Line 16: | Line 17: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Arthritis]] | |||
[[Category:Dermatology]] | |||
[[Category:Diseases involving the fasciae]] | |||
[[Category:Rheumatology]] | |||
[[Category:Nephrology]] | |||
[[Category:Autoimmune diseases]] | |||
[[Category:Disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:33, 28 September 2012
Systemic lupus erythematosus Microchapters |
Differentiating Systemic lupus erythematosus from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Systemic lupus erythematosus risk factors On the Web |
American Roentgen Ray Society Images of Systemic lupus erythematosus risk factors |
Directions to Hospitals Treating Systemic lupus erythematosus |
Risk calculators and risk factors for Systemic lupus erythematosus risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Risk Factors
The underlying cause of this autoimmune disease is not clear. Clinical data shows that the onset of systemic lupus erythematosus is associated with the following factors:
- Female: SLE affects nine times as many women as men.
- Age: From 10 to 50 yrs
- Race: African Americans and Asians are affected more often than people from other races.
- Drugs, such as chlorpromazine, hydralazine, isoniazid, methyldopa, penicillamine, procainamide, quinidine and sulfasalazine.
- People with relatives who suffer from SLE, rheumatoid arthritis or thrombotic thrombocytopenic purpura are at a slightly higher risk than the general population.[1]
References
- ↑ DiGeronimo, Theresa. New Hope for People with Lupus. Prima Publishing. 2002.